Takahito Sugase

Osaka International Cancer Institute

Papers

6

Total Citations

41

H-Index

3

About

Dr. Takahito Sugase is a pioneering surgical oncologist whose research centers on advanced minimally invasive surgical techniques for gastric and lower rectal cancers, with a particular focus on robotic surgery and emerging targeted therapies. His major contributions include demonstrating the feasibility and safety of robotic total gastrectomy with thrombectomy and portal vein reconstruction for gastric cancer with portal vein tumor thrombus—a procedure previously limited to highly invasive laparotomy. Dr. Sugase has also advanced the field through his work on learning curves for robot-assisted lateral lymph node dissection, providing critical benchmarks for surgical training. His investigations into zolbetuximab-based chemotherapy for CLDN18.2-positive gastroesophageal junction cancer, including conversion surgery after targeted therapy, represent a novel intersection of precision oncology and surgical intervention. With over 40 citations across his most-cited works, Dr. Sugase’s research has directly informed clinical practice, particularly in reducing postoperative complications such as pancreatic fistula through robotic distal gastrectomy. His comparative studies of robotic versus laparoscopic gastrectomy, demonstrating comparable three-year survival outcomes with improved perioperative performance, have helped establish robotic approaches as viable alternatives in gastric cancer surgery.

Research Focus

Key Achievements

3
H-Index
6
Papers
41
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer
13 citations · 2025
📈 Most Prolific Year: 2025 (4 Papers)
🤝 Key Collaborators: 67
🏛 Institutions: Osaka International Cancer Institute

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago